Plain-English translation of NCT07651878 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Norway
Sponsor
Mendus
Collaborators
TFS HealthScience, Clinfidence B.V.
Enrollment target
~24 participants
Started
April 2026
Primary completion
September 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
annelies Legters, MSC
Mendus BV
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.